Sustained delivery

How modified T cells could enable stable, long-term therapeutic protein delivery

Researchers from Vanderbilt University School of Medicine and Baylor College of Medicine have developed a new method for stable, long-term delivery of therapeutic proteins using antigen-specific T cells whose genomes have been modified with a transposon system. The approach could enable more regulated dosing than recombinant protein therapies delivered

Read the full 498 word article

How to gain access

Continue reading with a
two-week free trial.